FEMY Femasys Inc
Company Analysis
Latest News
🔴 Femasys is trading 10.1% down today amid broader risk-off trading
Femasys is trading at $2.68, down -10.07%, amid broader risk-off trading. - No new company-specific announcement was identified for September 8, 2026; recent...
🔴 Femasys is trading 5% down today amid declines in major indexes
Femasys is trading at $2.83 (-5.03%) amid broader market weakness on September 8, 2026. - The Dow Jones is down 1.24%, the S&P 500 is down 0.49%, and the...
Femasys registers 28.1M shares for resale, auditor flags going-concern risk
Femasys Inc. filed an SEC registration statement for the potential resale of up to 28.1 million common shares. These securities relate to a $30 million private...
🔴 Femasys is trading 5.7% down today with no clear catalyst identified
Femasys is trading at $3.08, down -5.67%, with no clear catalyst identified. - No company-specific announcement dated September 2, 2026 appears on Femasys’s...
🔴 Femasys is trading 6.12% down today amid renewed U.S.-Iran tensions
Femasys is trading at $3.22, down -6.12% during the September 1, 2026 session as U.S. stocks weaken amid renewed U.S.-Iran tensions, higher oil prices, and...
🟢 Femasys is trading 6.25% up today after UNC Health partnership expands fertility portfolio distribution
Femasys is trading 6.25% up now at $3.40 after investors continued responding to the August 26, 2026 partnership with UNC Health. - The agreement expands...
🟢 Femasys is trading 10% up today after UNC Health partnership expands fertility care statewide
Femasys is trading 10.04% up now at $3.07 after continued investor reaction to its August 26, 2026 partnership with UNC Health. - The agreement will introduce...
🟢 Femasys is trading 6.6% up today after UNC Health partnership expands fertility care access
Femasys is trading 6.63% up now at $2.98 after continued investor reaction to its UNC Health partnership. - The agreement brings FemVue, SpermVue, and...
Femasys Lands a Big-Name Hospital Partner, but Can a $3 Stock With Shrinking Revenue Turn Validation Into Real Growth?
Shares of Femasys shifted sharply higher Thursday, up 7.2% to $2.99, after the micro-cap fertility device maker announced a deal to place its diagnostic and...
🟢 Femasys is trading 7.17% up in pre-market after UNC Health deal to distribute fertility products
Femasys is trading at $2.99, up 7.17% in pre-market on August 28, 2026, following its partnership with UNC Health to distribute FemVue, SpermVue, and FemaSeed...
Femasys partners with UNC Health, offering fertility treatments without specialist referrals
Femasys Inc. partnered with UNC Health to distribute fertility products across North Carolina OB/GYN locations. The collaboration allows UNC Health providers...
🔴 Femasys is trading 6.16% down today — no clear catalyst identified
Femasys is trading at $2.74, down -6.16%, with no clear company-specific catalyst identified. - The latest major catalyst was the August 19 FDA modular PMA...
🔴 Femasys is trading 6.76% down in pre-market, possibly reflecting profit-taking
Femasys is trading 6.76% down at $2.76, possibly reflecting profit-taking after recent gains, though no company-specific catalyst has been confirmed. - No...
🟢 Femasys is trading 11.72% up today after FDA approval of modular PMA pathway
Femasys is trading 11.72% up now at $3.05 after the FDA approved a modular PMA pathway for investigational FemBloc. - The pathway lets the FDA review...
🟢 Femasys is trading 5% up today after FDA approved modular PMA pathway for FemBloc
Femasys is trading 5% up now at $2.87 after the FDA approved a modular PMA pathway for investigational FemBloc, its non-surgical permanent birth-control...
🔴 Femasys is trading 8.55% down in pre-market after investors took profits following FDA pathway approval
Femasys is trading 8.55% down in pre-market at $2.50 after investors took profits following the FDA’s modular PMA pathway approval for investigational...
🔴 Femasys is trading 6.27% down today as investors take profits after FDA pathway rally
Femasys is trading 6.27% down today at $2.54 as investors take profits following yesterday's significant rally. - Femasys surged 23.18% on August 19 after the...
🔴 Femasys is trading 10.68% down in pre-market after an August 19 rally
Femasys is trading at $2.42, down -10.68%, following a sharp August 19 rally after the FDA approved a modular PMA pathway for FemBloc. - The decision allows...
Femasys Gets a Regulatory Green Light for Its Birth-Control Device — But Can a $8 Million Company Turn Paperwork Into Profits?
Shares of Femasys (FEMY) sank -7.7% to $2.50 in pre-market trading on August 20, one day after a euphoric rally that saw the stock spike as high as $3.69...
🔴 Femasys is trading 7.75% down in pre-market after profit-taking following FDA’s modular PMA pathway approval
Femasys is trading at $2.50 (-7.75%) in pre-market on August 20, 2026, with weakness appearing to reflect profit-taking after FDA approval of a modular PMA...